NexGard COMBO for cats EMA marketing authorization

Boehringer Ingelheim receives EMA marketing authorization  for NexGard® COMBO, the first isoxazoline-based full endectocide for catsThe product features a triple action formula that includes esafoxolaner – the newly developed form of afoxolaner - combined with eprinomectin and praziquantel.This innovative broad spectrum topical parasiticide is easy and convenient for cat owners.It kills a wider range of parasites than any other product on the market, covering core external parasites like fleas and ticks as well as internal parasites, including tapeworms.
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news